These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


460 related items for PubMed ID: 19136741

  • 1. Hemorheological changes in solid tumor patients after treatment with recombinant erythropoetin.
    Muravyov AV, Cheporov SV, Kislov NV, Volkova EL.
    Clin Hemorheol Microcirc; 2009; 41(1):39-47. PubMed ID: 19136741
    [Abstract] [Full Text] [Related]

  • 2. Comparative efficiency and hemorheological consequences of hemotransfusion and epoetin therapy in anemic cancer patients.
    Muravyov AV, Cheporov SV, Kislov NV, Bulaeva SV, Maimistova AA.
    Clin Hemorheol Microcirc; 2010; 44(2):115-23. PubMed ID: 20203366
    [Abstract] [Full Text] [Related]

  • 3. Red blood cell aggregation changes are depended on its initial value: Effect of long-term drug treatment and short-term cell incubation with drug.
    Muravyov AV, Tikhomirova IA, Maimistova AA, Bulaeva SV, Mikhailov PV, Kislov NV.
    Clin Hemorheol Microcirc; 2011; 48(4):231-40. PubMed ID: 22012828
    [Abstract] [Full Text] [Related]

  • 4. Extra- and intracellular signaling pathways under red blood cell aggregation and deformability changes.
    Muravyov AV, Tikhomirova IA, Maimistova AA, Bulaeva SV.
    Clin Hemorheol Microcirc; 2009; 43(3):223-32. PubMed ID: 19923692
    [Abstract] [Full Text] [Related]

  • 5. The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients.
    Muravyov AV, Yakusevich VV, Surovaya L, Petrochenko A.
    Clin Hemorheol Microcirc; 2004; 31(4):251-6. PubMed ID: 15567894
    [Abstract] [Full Text] [Related]

  • 6. Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: the molecular change mechanisms after pentoxifylline treatment.
    Muravyov AV, Bulaeva SV, Tikhomirova IA, Zamishlayev AV, Uzikova EV, Miloradov MJ.
    Clin Hemorheol Microcirc; 2011; 49(1-4):431-9. PubMed ID: 22214714
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A.
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [Abstract] [Full Text] [Related]

  • 8. Crosstalk between adenylyl cyclase signaling pathway and Ca2+ regulatory mechanism under red blood cell microrheological changes.
    Muravyov AV, Tikhomirova IA, Maimistova AA, Bulaeva SV, Zamishlayev AV, Batalova EA.
    Clin Hemorheol Microcirc; 2010 Sep; 45(2-4):337-45. PubMed ID: 20675917
    [Abstract] [Full Text] [Related]

  • 9. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin].
    Delamaire M, Durand F, Hamel D, Joyeux V, Lepogamp P, Genetet B.
    J Mal Vasc; 1991 Sep; 16(3):289-94. PubMed ID: 1940657
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Haemorheological changes in uraemic children in response to erythropoietin treatment.
    Böhler T, Leo A, Linderkamp O, Braun A, Schärer K.
    Nephrol Dial Transplant; 1993 Sep; 8(2):140-5. PubMed ID: 8384334
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epoetin Beta once-weekly therapy in anemic patients with solid tumors and non-myeloid hematological malignancies receiving chemotherapy.
    Spaëth D, Desablens B, Rodon P, Mennecier B, Oudard S, Moullet I, Ghomari K, Bergougnoux L, Bleuzen P, Jenabian A, Ifrah N.
    Oncology; 2008 Sep; 74(1-2):112-8. PubMed ID: 18547966
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of weekly epoetin Beta in the treatment of chemotherapy-induced anemia in solid tumors].
    Oudard S, Quoix E, Jenabian A, Bergougnoux L, Chouahnia K, Ferrero JM, Misset JL, Spaëth D.
    Therapie; 2009 Sep; 64(1):17-25. PubMed ID: 19463249
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
    Heras P, Kritikos K, Hatzopoulos A, Mitsibounas D.
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):619-23. PubMed ID: 18707619
    [Abstract] [Full Text] [Related]

  • 17. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
    Koltai K, Feher G, Kesmarky G, Keszthelyi Z, Czopf L, Toth K.
    Clin Hemorheol Microcirc; 2006 Nov; 35(4):517-25. PubMed ID: 17148851
    [Abstract] [Full Text] [Related]

  • 18. [Role of protein kinases of human red cell membrane in deformability and aggregation changes].
    Murav'ev AV, Maĭmistova AA, Tikhomirova IA, Bulaeva SV, Mikhaĭlov PV, Murav'ev AA.
    Fiziol Cheloveka; 2012 Nov; 38(2):94-100. PubMed ID: 22679802
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hemorheological parameters in children with iron-deficiency anemia and the alterations in these parameters in response to iron replacement.
    Halis H, Bor-Kucukatay M, Akin M, Kucukatay V, Bozbay I, Polat A.
    Pediatr Hematol Oncol; 2009 Nov; 26(3):108-18. PubMed ID: 19382032
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.